Paradoxical psoriatic arthritis (PPsA) may be associated with guselkumab treatment. We describe a patient in whom PPsA required a change from guselkumab to ixekizumab. The pathophysiology of this paradoxical reaction is most likely a cytokine imbalance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ced.15061 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
New onset inflammatory bowel disease after initiation of anti-IL-17a treatment: a case series.
Acta Gastroenterol Belg
October 2024
Department of Gastroenterology, University Hospital Ghent, Ghent, Belgium.
Immune mediated inflammatory diseases (IMIDs) are a heterogenous group of inflammatory disorders of joint, skin, and gut characterized by both shared and distinct pathological pathways. This complexity has therapeutic implications, as not all IMIDs exhibit responsiveness to available biologicals. Moreover, cases have been documented where patients undergoing biologic therapy experience paradoxical occurrences of either a new IMID or a flare-up of a previously asymptomatic one.
View Article and Find Full Text PDFCertolizumab-induced sarcoidosis in a patient with psoriatic arthritis - a case report and review of literature.
Rheumatol Int
October 2024
Department of Rheumatology and Immunology, Jagiellonian University Medical College, ul. Jakubowskiego 2, Krakow, 30-688, Poland.
Tumour necrosis factor-α (TNF- α) antagonists are considered a significant therapeutic option in the treatment of sarcoidosis. Nevertheless, their use can also paradoxically result in sarcoidosis-like reactions. Here, we present a case of a 56-year-old patient with psoriatic arthritis who after 3 months of certolizumab therapy developed pulmonary sarcoidosis.
View Article and Find Full Text PDFMucocutaneous manifestations of inflammatory bowel disease.
Ann Dermatol Venereol
September 2024
Dermatology Department, North Hospital, Assistance-Publique Hopitaux de Marseille, Aix-Marseille University, Marseille, France.
Article Synopsis
- * Inflammatory bowel disease (IBD) is closely associated with various skin issues, categorized into four groups: reactive manifestations, Crohn's-specific lesions, nutritional deficiencies, and independent autoimmune/inflammatory skin diseases.
- * Dermatologists play a role in treating adverse effects from IBD treatments, particularly concerning paradoxical reactions like psoriatic eruptions.
Unintended Consequences of Immune Therapy for Immune-Mediated Diseases: Paradoxical Psoriasis and Dupilumab-Associated Musculoskeletal Syndrome.
J Rheumatol
October 2024
B. Kirkham, MD, Rheumatology Department, Guy's and St Thomas' Hospital Foundation Trust, and Kings College London, London, UK.
Two presentations at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting focused on unintended consequences of immunomodulatory therapy for psoriasis (PsO). Dr. Elizabeth Wallace presented on unintended consequences of tumor necrosis factor inhibitors for treating PsO and other inflammatory disorders.
View Article and Find Full Text PDFAdalimumab induced psoriasis in a Crohn's disease patient: A case report.
J Pak Med Assoc
July 2024
Department of Dermatology, Northern Border University, Arar, Saudi Arabia.
Article Synopsis
- * A 37-year-old male developed palmoplantar psoriasis as an adverse reaction after using adalimumab to treat his Crohn's disease.
- * Despite trying several potent corticosteroids, the psoriasis did not fully clear, leading to a referral to the rheumatologist for a possible change in therapy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!